Abpro Holdings Inc(ABP) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -12.45 | Insider Own | 36.26% | Shs Outstand | 2.7M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.7M | Perf Month | -72.53% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 1.71% | Short Float | 2.6% | Perf Quarter | -91.79% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | -11.1% | Short Ratio | 0.03 | Perf Half Y | -93.2% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -248.15% | Short Interest | 0.04M | Perf YTD | -87.66% |
| Book/sh | -6.04 | P/C | 4.18 | EPS past 3/5Y | -2359.24% - | ROE | - | 52W High | -98.26% ($29.97) | Perf Year | -98.15% |
| Cash/sh | 0.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 0.96% ($0.52) | Perf 3Y | -99.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -95.93% | Gross Margin | - | Volatility(W/M) | 35.22% 26.35% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.07 | EPS Q/Q | 48.6% | Profit Margin | - | RSI (14) | 22.04 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.07 | Sales Q/Q | - | SMA20 | -65.53% ($1.51) | Beta | 0.11 | Target Price | $60 |
| Payout | - | Debt/Eq | - | Earnings | 2025/09/03 | SMA50 | -84.13% ($3.28) | Rel Volume | 0 | Prev Close | $0.52 |
| Employees | 6 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -90.96% ($5.75) | Avg Volume(3M) | 1.67M | Price | $0.52 |
| IPO | 2022/3/9 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
🧬 Aprogen Holdings (ABP) is a next-generation immuno-oncology drug discovery biotech company that develops bispecific antibodies for solid tumor-targeted therapies such as breast cancer and gastric cancer using its proprietary DiversiMab platform technology.
Over the past 1 year, on the lower side
98% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
ABP has weak earnings and a weak balance sheet
Review management risk carefully before investing
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -99.8%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 1.7%.
Tap to view numbers
It ranks #587 of 596 in the industry
Based on market cap of $1M.
LNAI#585 Lunai Bioworks Inc $1M PER - 
GNPX#586 Genprex Inc $1M PER - ABP#587 Abpro Holdings Inc $1M PER - 
ARTL#587 Artelo Biosciences Inc $1M PER - 
MLEC#588 Moolec Science SA $1M PER - 
FAQ
What kind of company is ABP?
ABP belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of ABP?
The market cap of ABP is approximately $1M, ranking 5,836 within its sector.
What is the 52-week high and low for ABP?
ABP has recorded a 52-week high of $29.97 and a low of $0.52.
